Panelist Bios


Leslie Trigg

Leslie was previously Outset’s Chief Operating Officer and an Executive-in-Residence at Warburg Pincus. Prior to Outset, she was Executive Vice President at Lutonix, a cardiovascular medical device company acquired by CR Bard. Prior to Lutonix, Leslie served as Chief Business Officer of AccessClosure, a vascular closure company acquired by Cardinal Health. Before joining AccessClosure, she was the Vice President, Marketing for FoxHollow Technologies, helping to architect the strategy and commercial infrastructure that led to a successful IPO and subsequent acquisition by ev3/Covidien. Leslie’s management experience also includes senior leadership positions at Cytyc Corporation and breast cancer diagnostics company Pro-Duct Health, Inc., which was acquired by Cytyc. She began her medical device career at Guidant Corporation in new product global marketing. Leslie is currently a board member of Cardiovascular Systems, Inc. (NASDAQ: CSII).